Comprehensive Review on Current Interventions, Diagnostics, and Nanotechnology Perspectives against SARS-CoV-2
暂无分享,去创建一个
[1] I Rovira,et al. Nitric oxide , 2021, Reactions Weekly.
[2] S. Nelson,et al. COVID‐19 drug repurposing: Summary statistics on current clinical trials and promising untested candidates , 2020, Transboundary and emerging diseases.
[3] A. Tsatsakis,et al. SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches—Insights into Chemical Structure—Biological Activity and Toxicological Screening , 2020, Journal of clinical medicine.
[4] P. Conti,et al. Dexamethasone for COVID-19? Not so fast. , 2020, Journal of biological regulators and homeostatic agents.
[5] Emily G McDonald,et al. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 , 2020, The New England journal of medicine.
[6] J. Peiris,et al. Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections. , 2020, Cell reports.
[7] J. Peiris,et al. Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections. , 2020, Cell reports.
[8] Amit N. Patel,et al. RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis , 2020, The Lancet.
[9] Fang Li,et al. Cell entry mechanisms of SARS-CoV-2 , 2020, Proceedings of the National Academy of Sciences.
[10] Sonu Gandhi,et al. eCovSens-Ultrasensitive Novel In-House Built Printed Circuit Board Based Electrochemical Device for Rapid Detection of nCovid-19 antigen, a spike protein domain 1 of SARS-CoV-2 , 2020, bioRxiv.
[11] V. Pelechano,et al. Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform , 2020, Clinical chemistry.
[12] Daeui Park,et al. Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor , 2020, ACS nano.
[13] G. Kullak-Ublick,et al. Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 Detection , 2020, ACS nano.
[14] J. Lisziewicz,et al. Precision COVID-19 Vaccine with Companion Diagnostics , 2020, Precision Nanomedicine.
[15] Stefano Pascarella,et al. Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy , 2020, Journal of Infection.
[16] Zacharias E. Andreadakis,et al. The COVID-19 vaccine development landscape , 2020, Nature Reviews Drug Discovery.
[17] Hongming Miao,et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study , 2020, Signal Transduction and Targeted Therapy.
[18] L. Saif. VACCINES FOR COVID-19: PERSPECTIVES, PROSPECTS, AND CHALLENGES BASED ON CANDIDATE SARS, MERS, AND ANIMAL CORONAVIRUS VACCINES , 2020, European Medical Journal.
[19] Tony Y. Hu,et al. Insights from nanomedicine into chloroquine efficacy against COVID-19 , 2020, Nature Nanotechnology.
[20] O. Tsang,et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study , 2020, The Lancet Infectious Diseases.
[21] M. Cascella,et al. Features, Evaluation and Treatment Coronavirus (COVID-19) , 2020 .
[22] Mandeep R. Mehra,et al. COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal , 2020, The Journal of Heart and Lung Transplantation.
[23] Rui-guang Zhang,et al. Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] Han-Ming Shen,et al. Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19 , 2020, International journal of biological sciences.
[25] Cynthia Liu,et al. Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases , 2020, ACS central science.
[26] A. Walls,et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.
[27] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[28] Z. Memish,et al. Remdesivir as a possible therapeutic option for the COVID-19 , 2020, Travel Medicine and Infectious Disease.
[29] Jia Zhou,et al. Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential , 2020, ACS infectious diseases.
[30] Dyna Rochmyaningsih. Indonesia finally reports two coronavirus cases. Scientists worry it has many more , 2020 .
[31] W. Tu,et al. Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit , 2020, Intensive Care Medicine.
[32] Bin Du,et al. Critical care crisis and some recommendations during the COVID-19 epidemic in China , 2020, Intensive Care Medicine.
[33] Tai Hing Lam,et al. Mass masking in the COVID-19 epidemic: people need guidance , 2020, The Lancet.
[34] Anders Wolff,et al. 2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics , 2020, Micromachines.
[35] N. Tanner,et al. Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP , 2020, medRxiv.
[36] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[37] De-Min Han,et al. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality , 2020, Frontiers in Public Health.
[38] Ping Liu,et al. A Peptide-based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019 (COVID-19) , 2020, medRxiv.
[39] Long Jiang Zhang,et al. Coronavirus Disease 2019 (COVID-19): A Perspective from China , 2020, Radiology.
[40] Young-Jun Park,et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.
[41] Huachen Zhu,et al. Identification of 2019-nCoV related coronaviruses in Malayan pangolins in southern China , 2020, bioRxiv.
[42] Michael B. Chancellor,et al. Rapid Detection of Novel Coronavirus (COVID-19) by Reverse Transcription-Loop-Mediated Isothermal Amplification , 2020, medRxiv.
[43] DermaMed Otc. Aluminum Hydroxide , 2020, Definitions.
[44] Federico M Giorgi,et al. Genomic variance of the 2019‐nCoV coronavirus , 2020, Journal of medical virology.
[45] Yan Zhao,et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) , 2020, Military Medical Research.
[46] Gengfu Xiao,et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro , 2020, Cell Research.
[47] J. Stephenson. Coronavirus Outbreak-an Evolving Global Health Emergency. , 2020, JAMA health forum.
[48] E. Holmes,et al. A new coronavirus associated with human respiratory disease in China , 2020, Nature.
[49] Kai Zhao,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.
[50] S. Lindstrom,et al. First Case of 2019 Novel Coronavirus in the United States , 2020, The New England journal of medicine.
[51] Huji Xu,et al. The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes , 2020, bioRxiv.
[52] Christian Drosten,et al. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells , 2020, bioRxiv.
[53] E. Holmes,et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.
[54] Ting Yu,et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.
[55] Weier Wang,et al. Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China , 2020, Journal of medical virology.
[56] Jing Zhao,et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.
[57] W. Lipkin,et al. From SARS-CoV to Wuhan 2019-nCoV Outbreak: Similarity of Early Epidemic and Prediction of Future Trends , 2020, bioRxiv.
[58] G. Gao,et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.
[59] Lisa E. Gralinski,et al. Return of the Coronavirus: 2019-nCoV , 2020, Viruses.
[60] S. Haam,et al. Porous gold nanoparticles for attenuating infectivity of influenza A virus , 2020, Journal of Nanobiotechnology.
[61] R. Baric,et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV , 2020, Nature Communications.
[62] Wei Zhang,et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes , 2020, Emerging microbes & infections.
[63] H. Gendelman,et al. Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues , 2020, Theranostics.
[64] Naveen Vankadari,et al. Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26 , 2020, Emerging microbes & infections.
[65] K. To,et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan , 2020, Emerging microbes & infections.
[66] Zhènglì Shí,et al. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody , 2020, bioRxiv.
[67] F. Holsboer,et al. SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection , 2019, Nature Communications.
[68] M. A. Garza-Navarro,et al. Virucidal Activity of Gold Nanoparticles Synthesized by Green Chemistry Using Garlic Extract , 2019, Viruses.
[69] D. Shin,et al. Inhibition of SARS-CoV 3CL protease by flavonoids , 2019, Journal of enzyme inhibition and medicinal chemistry.
[70] Max J. Kellner,et al. SHERLOCK: nucleic acid detection with CRISPR nucleases , 2019, Nature Protocols.
[71] Hyojin Kim,et al. Characteristics of flavonoids as potent MERS‐CoV 3C‐like protease inhibitors , 2019, Chemical biology & drug design.
[72] T. Ohlmann,et al. Selenium, Selenoproteins and Viral Infection , 2019, Nutrients.
[73] H. Danafar,et al. Tumor Targeted Albumin Coated Bismuth Sulfide Nanoparticles (Bi2S3) as Radiosensitizers and Carriers of Curcumin for Enhanced Chemoradiation Therapy. , 2019, ACS biomaterials science & engineering.
[74] R. Löbenberg,et al. Niclosamide repositioning for treating cancer: Challenges and nano-based drug delivery opportunities. , 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[75] P. Shende,et al. Diversity of β-cyclodextrin-based nanosponges for transformation of actives. , 2019, International journal of pharmaceutics.
[76] Wei Zhang,et al. Catalytic Mechanisms of Nanozymes and Their Applications in Biomedicine. , 2019, Bioconjugate chemistry.
[77] Mauro Ferrari,et al. Clinical Cancer Nanomedicine. , 2019, Nano today.
[78] Jiang,et al. Cross-Kingdom Small RNAs among Animals, Plants and Microbes , 2019, Cells.
[79] S. Pillet,et al. A plant-derived VLP influenza vaccine elicits a balanced immune response even in very old mice with co-morbidities , 2019, PloS one.
[80] M. O’Connell,et al. Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR-Cas Systems. , 2019, Journal of molecular biology.
[81] Á. Somoza,et al. Targeting autophagy using metallic nanoparticles: a promising strategy for cancer treatment , 2018, Cellular and Molecular Life Sciences.
[82] S. Mostowy,et al. Autophagy-Virus Interplay: From Cell Biology to Human Disease , 2018, Front. Cell Dev. Biol..
[83] M. Ferrari,et al. Chloroquine and nanoparticle drug delivery: A promising combination , 2018, Pharmacology & therapeutics.
[84] M. Shamsipur,et al. Recent advances in designing nanomaterial based biointerfaces for electrochemical biosensing cardiovascular biomarkers , 2018, Journal of pharmaceutical and biomedical analysis.
[85] Leonardo Fernandes Fraceto,et al. Nano based drug delivery systems: recent developments and future prospects , 2018, Journal of Nanobiotechnology.
[86] Ze Chen,et al. Comparative effectiveness of H7N9 vaccines in healthy individuals , 2018, Human vaccines & immunotherapeutics.
[87] Hye Kyu Choi,et al. Application of Gold Nanoparticle to Plasmonic Biosensors , 2018, International journal of molecular sciences.
[88] M. Olesińska,et al. Antimalarials – are they effective and safe in rheumatic diseases? , 2018, Reumatologia.
[89] F. Trotta,et al. Investigation of Cyclodextrin-Based Nanosponges for Solubility and Bioavailability Enhancement of Rilpivirine , 2018, AAPS PharmSciTech.
[90] M. Shamsipur,et al. Advances in the design of nanomaterial-based electrochemical affinity and enzymatic biosensors for metabolic biomarkers: A review , 2018, Microchimica Acta.
[91] Xiaotao Lu,et al. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease , 2018, mBio.
[92] Shi-jia Ding,et al. Highly sensitive surface plasmon resonance biosensor for the detection of HIV-related DNA based on dynamic and structural DNA nanodevices. , 2018, Biosensors & bioelectronics.
[93] Xiaobin Fan,et al. Preparation of Cuprous Oxide Mesoporous Spheres with Different Pore Sizes for Non-Enzymatic Glucose Detection , 2018, Nanomaterials.
[94] S. Baikerikar. Curcumin and Natural Derivatives Inhibit Ebola Viral Proteins: An In silico Approach , 2017, Pharmacognosy research.
[95] Jacqueline Farinha Shimizu,et al. Flavonoids from Pterogyne nitens Inhibit Hepatitis C Virus Entry , 2017, Scientific Reports.
[96] N. Chand,et al. Nano cellulose dispersed chitosan film with Ag NPs/Curcumin: An in vivo study on Albino Rats for wound dressing. , 2017, International journal of biological macromolecules.
[97] M. Chikindas,et al. Antimicrobial efficacy of curcumin nanoparticles against Listeria monocytogenes is mediated by surface charge , 2017 .
[98] J. Kuller,et al. Hepatitis C in pregnancy: screening, treatment, and management. , 2017, American journal of obstetrics and gynecology.
[99] M. Ferrari,et al. A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery , 2017, Scientific Reports.
[100] D. Kalman,et al. Curcumin: A Review of Its’ Effects on Human Health , 2017, Foods.
[101] A. Chilkoti,et al. Niclosamide-conjugated polypeptide nanoparticles inhibit Wnt signaling and colon cancer growth. , 2017, Nanoscale.
[102] K. Sudhakar,et al. Green Synthesis and Characterization of Halloysite Nanoclay/Curcumin/Ag Hybrid Nano Materials for Antibacterial Applications , 2017, Journal of Inorganic and Organometallic Polymers and Materials.
[103] M. Vignuzzi,et al. Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding , 2017, Antiviral research.
[104] Zhiqiang Ma,et al. Curcumin as a potential protective compound against cardiac diseases , 2017, Pharmacological research.
[105] J. Stoddard,et al. Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults , 2017, Immunity & Ageing.
[106] Aviv Regev,et al. Nucleic acid detection with CRISPR-Cas13a/C2c2 , 2017, Science.
[107] Jaesung Jang,et al. Label-free Detection of Influenza Viruses using a Reduced Graphene Oxide-based Electrochemical Immunosensor Integrated with a Microfluidic Platform , 2017, Scientific Reports.
[108] I. Wilson,et al. Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol , 2016, Proceedings of the National Academy of Sciences.
[109] R. Bowen,et al. Inactivation of Middle East respiratory syndrome coronavirus (MERS‐CoV) in plasma products using a riboflavin‐based and ultraviolet light‐based photochemical treatment , 2016, Transfusion.
[110] Hakan Inan,et al. Advances in biosensing strategies for HIV-1 detection, diagnosis, and therapeutic monitoring. , 2016, Advanced drug delivery reviews.
[111] James Jungho Pak,et al. A multi-virus detectable microfluidic electrochemical immunosensor for simultaneous detection of H1N1, H5N1, and H7N9 virus using ZnO nanorods for sensitivity enhancement , 2016 .
[112] Yànfāng Zhāng,et al. Silver nanoparticles coated graphene electrochemical sensor for the ultrasensitive analysis of avian influenza virus H7. , 2016, Analytica chimica acta.
[113] G. Glenn,et al. A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age. , 2016, The Journal of infectious diseases.
[114] K. Tanonaka,et al. Angiotensin-converting enzyme 2. , 2016, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.
[115] C. Huang,et al. Curcumin modified silver nanoparticles for highly efficient inhibition of respiratory syncytial virus infection. , 2016, Nanoscale.
[116] Yang Liu,et al. Nanozyme-strip for rapid local diagnosis of Ebola. , 2015, Biosensors & bioelectronics.
[117] Andriy Kuzmov,et al. Nanotechnology approaches for inhalation treatment of lung diseases. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[118] E. Won,et al. Combination Therapy with Lopinavir/Ritonavir, Ribavirin and Interferon-α for Middle East Respiratory Syndrome , 2015, Antiviral therapy.
[119] Gabor T. Marth,et al. A global reference for human genetic variation , 2015, Nature.
[120] Tatiana Ammosova,et al. Inhibition of HIV-1 by curcumin A, a novel curcumin analog , 2015, Drug design, development and therapy.
[121] Sharmistha Banerjee,et al. The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update. , 2015, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[122] G. Glenn,et al. ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans. , 2015, Vaccine.
[123] Y. Chai,et al. An amplified electrochemical immunosensor based on in situ-produced 1-naphthol as electroactive substance and graphene oxide and Pt nanoparticles functionalized CeO2 nanocomposites as signal enhancer. , 2015, Biosensors & bioelectronics.
[124] D. Pang,et al. Bifunctional magnetic nanobeads for sensitive detection of avian influenza A (H7N9) virus based on immunomagnetic separation and enzyme-induced metallization. , 2015, Biosensors & bioelectronics.
[125] F. Ungaro,et al. Toward Repositioning Niclosamide for Antivirulence Therapy of Pseudomonas aeruginosa Lung Infections: Development of Inhalable Formulations through Nanosuspension Technology. , 2015, Molecular pharmaceutics.
[126] Xi Zheng,et al. Curcumin, Inflammation, and Chronic Diseases: How Are They Linked? , 2015, Molecules.
[127] A. Fatiregun,et al. An overview of disease surveillance and notification system in Nigeria and the roles of clinicians in disease outbreak prevention and control , 2015, Nigerian medical journal : journal of the Nigeria Medical Association.
[128] Yuming Dong,et al. Label-free colorimetric sensor for mercury(II) and DNA on the basis of mercury(II) switched-on the oxidase-mimicking activity of silver nanoclusters. , 2015, Analytica chimica acta.
[129] H. Ishida,et al. Cytotoxic activities of CD8+ T cells collaborate with macrophages to protect against blood-stage murine malaria , 2015, eLife.
[130] M. Kumari,et al. Green synthesis and applications of Au-Ag bimetallic nanoparticles. , 2015, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[131] Robert C. G. Martin,et al. Gold nanorods and curcumin-loaded nanomicelles for efficient in vivo photothermal therapy of Barrett's esophagus. , 2015, Nanomedicine.
[132] A. Mesecar,et al. The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds , 2014, Antiviral Research.
[133] A. Surolia,et al. Formulation of nanotized curcumin and demonstration of its antimalarial efficacy , 2014, International journal of nanomedicine.
[134] Q. Wei,et al. A label-free electrochemiluminescence immunosensor based on silver nanoparticle hybridized mesoporous carbon for the detection of Aflatoxin B1 , 2014 .
[135] A. Sirko,et al. Plant expression systems for production of hemagglutinin as a vaccine against influenza virus. , 2014, Acta biochimica Polonica.
[136] J. Connolly,et al. Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers. , 2014, Vaccine.
[137] J. Lippolis,et al. Acute phase response elicited by experimental bovine diarrhea virus (BVDV) infection is associated with decreased vitamin D and E status of vitamin-replete preruminant calves. , 2014, Journal of dairy science.
[138] David Heckerman,et al. HIV Control Is Mediated in Part by CD8+ T-Cell Targeting of Specific Epitopes , 2014, Journal of Virology.
[139] Jasmina Vidic,et al. Electrochemical detection of the oligomerization of PB1-F2 influenza A virus protein in infected cells. , 2014, Analytical chemistry.
[140] Piotr Orlowski,et al. Tannic Acid Modified Silver Nanoparticles Show Antiviral Activity in Herpes Simplex Virus Type 2 Infection , 2014, PloS one.
[141] W. Lim,et al. The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis , 2014, The Journal of infectious diseases.
[142] Donald J Buchsbaum,et al. Multi-targeted therapy of cancer by niclosamide: A new application for an old drug. , 2014, Cancer letters.
[143] R. Cavalli,et al. The application of nanosponges to cancer drug delivery , 2014, Expert opinion on drug delivery.
[144] K. Zandi,et al. A Review on Antibacterial, Antiviral, and Antifungal Activity of Curcumin , 2014, BioMed research international.
[145] S. Polyak,et al. Arbidol as a broad-spectrum antiviral: An update , 2014, Antiviral Research.
[146] A. Ingle,et al. Metal nanoparticles: The protective nanoshield against virus infection , 2014, Critical reviews in microbiology.
[147] A. Roy,et al. Curcumin: a review , 2014 .
[148] XinRan Li,et al. Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[149] V. Vaillant,et al. The French human Salmonella surveillance system: evaluation of timeliness of laboratory reporting and factors associated with delays, 2007 to 2011. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[150] J. Lisziewicz,et al. Safety, Tolerability, and Immunogenicity of Repeated Doses of DermaVir, a Candidate Therapeutic HIV Vaccine, in HIV-Infected Patients Receiving Combination Antiretroviral Therapy: Results of the ACTG 5176 Trial , 2013, Journal of acquired immune deficiency syndromes.
[151] Byung-Chan Kim,et al. Highly sensitive localized surface plasmon resonance immunosensor for label-free detection of HIV-1. , 2013, Nanomedicine : nanotechnology, biology, and medicine.
[152] A. Vlasova,et al. Effects of dietary vitamin A content on antibody responses of feedlot calves inoculated intramuscularly with an inactivated bovine coronavirus vaccine. , 2013, American journal of veterinary research.
[153] E. Wang,et al. Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes. , 2013, Chemical Society reviews.
[154] Victor M Corman,et al. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection , 2013, The Lancet Infectious Diseases.
[155] G. Boivin,et al. Influenza virus resistance to neuraminidase inhibitors. , 2013, Antiviral research.
[156] Takeshi Ono,et al. Antiviral activity of silver nanoparticle/chitosan composites against H1N1 influenza A virus , 2013, Nanoscale Research Letters.
[157] Cheng-Chung Chou,et al. Nucleic Acid Sandwich Hybridization Assay with Quantum Dot-Induced Fluorescence Resonance Energy Transfer for Pathogen Detection , 2012, Sensors.
[158] E. Riedmann. Human Vaccines & Immunotherapeutics , 2012, Human Vaccines & Immunotherapeutics.
[159] M. Zanetti,et al. Cyclodextrin-based nanosponges as drug carriers , 2012, Beilstein journal of organic chemistry.
[160] Heyou Han,et al. A fast and sensitive immunoassay of avian influenza virus based on label-free quantum dot probe and lateral flow test strip. , 2012, Talanta.
[161] S. Gorski,et al. Targeting autophagy , 2012, Autophagy.
[162] C. Severini,et al. Artemisinin and artemisinin plus curcumin liposomal formulations: enhanced antimalarial efficacy against Plasmodium berghei-infected mice. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[163] K. Imai,et al. Inactivation of high and low pathogenic avian influenza virus H5 subtypes by copper ions incorporated in zeolite-textile materials. , 2012, Antiviral research.
[164] Sang Yup Lee,et al. Development of label-free optical diagnosis for sensitive detection of influenza virus with genetically engineered fusion protein. , 2012, Talanta.
[165] S. Jo,et al. Quantitative and sensitive detection of SARS coronavirus nucleocapsid protein using quantum dots‐conjugated RNA aptamer on chip , 2011, Journal of chemical technology and biotechnology.
[166] T. Liang,et al. Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees , 2011, Hepatology.
[167] G. Glenn,et al. H5N1 Virus-Like Particle Vaccine Elicits Cross-Reactive Neutralizing Antibodies That Preferentially Bind to the Oligomeric Form of Influenza Virus Hemagglutinin in Humans , 2011, Journal of Virology.
[168] G. Glenn,et al. Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico , 2011, Vaccine.
[169] Bryan C Dickinson,et al. Chemistry and biology of reactive oxygen species in signaling or stress responses. , 2011, Nature chemical biology.
[170] Maosheng Yao,et al. Integrating silicon nanowire field effect transistor, microfluidics and air sampling techniques for real-time monitoring biological aerosols. , 2011, Environmental science & technology.
[171] V. Ward,et al. Cross‐presentation of epitopes on virus‐like particles via the MHC I receptor recycling pathway , 2011, Immunology and cell biology.
[172] Xianggang Liu,et al. Electrochemical detection of avian influenza virus H5N1 gene sequence using a DNA aptamer immobilized onto a hybrid nanomaterial-modified electrode , 2011 .
[173] F. Aqil,et al. Advanced Drug Delivery Systems of Curcumin for Cancer Chemoprevention , 2011, Cancer Prevention Research.
[174] Kwok-Hung Chan,et al. Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[175] Jianrong Li,et al. Vesicular Stomatitis Virus as a Vector To Deliver Virus-Like Particles of Human Norovirus: a New Vaccine Candidate against an Important Noncultivable Virus , 2011, Journal of Virology.
[176] Kai Ludwig,et al. Inhibition of influenza virus infection by multivalent sialic-acid-functionalized gold nanoparticles. , 2010, Small.
[177] P. Giustetto,et al. Nanosponge formulations as oxygen delivery systems. , 2010, International journal of pharmaceutics.
[178] A. Arnold,et al. Sex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17β-oestradiol-dependent and sex chromosome-independent , 2010, Biology of Sex Differences.
[179] F. Plummer,et al. Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology , 2010, mAbs.
[180] Fang Li,et al. Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor , 2009, Proceedings of the National Academy of Sciences.
[181] M. Meade,et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. , 2009, JAMA.
[182] Chien Chou,et al. Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in human serum using a localized surface plasmon coupled fluorescence fiber-optic biosensor , 2009, Biosensors and Bioelectronics.
[183] W. Barthlott,et al. Superhydrophobic and superhydrophilic plant surfaces: an inspiration for biomimetic materials , 2009, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[184] T. Burke,et al. An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells. , 2009, International journal of pharmaceutics.
[185] A. McMichael,et al. T Cell Responses to Whole SARS Coronavirus in Humans1 , 2008, The Journal of Immunology.
[186] Christian Melander,et al. Inhibition of HIV fusion with multivalent gold nanoparticles. , 2008, Journal of the American Chemical Society.
[187] S. Polyak,et al. Arbidol: a broad-spectrum antiviral compound that blocks viral fusion. , 2008, Current medicinal chemistry.
[188] Yung-Hyun Choi,et al. Curcumin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-stimulated BV2 microglia , 2007, Acta Pharmacologica Sinica.
[189] Yu Zhang,et al. Intrinsic peroxidase-like activity of ferromagnetic nanoparticles. , 2007, Nature nanotechnology.
[190] Po-Huang Liang,et al. Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. , 2007, Journal of medicinal chemistry.
[191] Y. Cheung,et al. Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope , 2007, Vaccine.
[192] Jae-We Cho,et al. Curcumin attenuates the expression of IL-1β, IL-6, and TNF-α as well as cyclin E in TNF-α-treated HaCaT cells; NF-κB and MAPKs as potential upstream targets , 2007 .
[193] E. Hempelmann. Hemozoin Biocrystallization in Plasmodium falciparum and the antimalarial activity of crystallization inhibitors , 2007, Parasitology Research.
[194] D. Leclerc,et al. Proteasome-Independent Major Histocompatibility Complex Class I Cross-Presentation Mediated by Papaya Mosaic Virus-Like Particles Leads to Expansion of Specific Human T Cells , 2006, Journal of Virology.
[195] D. Tough,et al. Direct Stimulation of T Cells by Type I IFN Enhances the CD8+ T Cell Response during Cross-Priming1 , 2006, The Journal of Immunology.
[196] D. Hui. An overview on severe acute respiratory syndrome (SARS). , 2005, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[197] J. Sprent,et al. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection , 2005, The Journal of experimental medicine.
[198] N. Seidah,et al. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread , 2005, Virology Journal.
[199] M. Yacamán,et al. Interaction of silver nanoparticles with HIV-1 , 2005, Journal of nanobiotechnology.
[200] M. Moskovits. Surface‐enhanced Raman spectroscopy: a brief retrospective , 2005 .
[201] J. Klingström,et al. Nitric Oxide Inhibits the Replication Cycle of Severe Acute Respiratory Syndrome Coronavirus , 2005, Journal of Virology.
[202] P. Chan,et al. Use of convalescent plasma therapy in SARS patients in Hong Kong , 2004, European Journal of Clinical Microbiology and Infectious Diseases.
[203] Jindrich Cinatl,et al. Ribavirin and interferon-β synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines , 2004, Biochemical and Biophysical Research Communications.
[204] Gengfeng Zheng,et al. Electrical detection of single viruses. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[205] Jie Li,et al. Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors1 , 2004, The Journal of Immunology.
[206] B. Murphy,et al. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus , 2004, Nature Medicine.
[207] Jinfang Zhang,et al. Piezoelectric immunosensor for SARS-associated coronavirus in sputum. , 2004, Analytical chemistry.
[208] B. Murphy,et al. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[209] J. Sung,et al. Retrospective comparison of convalescent plasma with continuing high‐dose methylprednisolone treatment in SARS patients , 2004, Clinical Microbiology and Infection.
[210] G. Navis,et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.
[211] Jindrich Cinatl,et al. HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus , 2004, Biochemical and Biophysical Research Communications.
[212] W. Barclay,et al. Changes in in vitro susceptibility of influenza A H3N2 viruses to a neuraminidase inhibitor drug during evolution in the human host. , 2004, The Journal of antimicrobial chemotherapy.
[213] Tae Woo Kim,et al. Generation and Characterization of DNA Vaccines Targeting the Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus , 2004, Journal of Virology.
[214] Y. Guan,et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings , 2004, Thorax.
[215] H. Hemilä. Vitamin C and SARS coronavirus , 2003, The Journal of antimicrobial chemotherapy.
[216] P. Borrow,et al. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon , 2003, Nature Immunology.
[217] H. Powers. Riboflavin (vitamin B-2) and health. , 2003, The American journal of clinical nutrition.
[218] Michael B Edmond,et al. Managing SARS amidst uncertainty. , 2003, The New England journal of medicine.
[219] D. Cyranoski. Critics slam treatment for SARS as ineffective and perhaps dangerous , 2003, Nature.
[220] S. Landolfo,et al. The interferon system: an overview. , 2002, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[221] F. Lechner,et al. Cross‐presentation of virus‐like particles by skin‐derived CD8– dendritic cells: a dispensable role for TAP , 2002, European journal of immunology.
[222] Y. Mori,et al. Detection of loop-mediated isothermal amplification reaction by turbidity derived from magnesium pyrophosphate formation. , 2001, Biochemical and biophysical research communications.
[223] T. Notomi,et al. Loop-mediated isothermal amplification of DNA. , 2000, Nucleic acids research.
[224] M. Schäfer-Korting,et al. Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[225] L. Simonsen,et al. The impact of influenza epidemics on hospitalizations. , 2000, The Journal of infectious diseases.
[226] R. Semba. Vitamin A and immunity to viral, bacterial and protozoan infections , 1999, Proceedings of the Nutrition Society.
[227] A. Amerik,et al. HIV-I protease , 1996, Applied biochemistry and biotechnology.
[228] P. Barnes,et al. Nitric oxide and airway disease. , 1995, Annals of medicine.
[229] C. Bates. Vitamin A , 1995, The Lancet.
[230] P. S. Kim,et al. A spring-loaded mechanism for the conformational change of influenza hemagglutinin , 1993, Cell.
[231] J. Sureshkumar,et al. Novel Coronavirus , 2020, Research Journal of Pharmacology and Pharmacodynamics.
[232] A. Şahin. 2019 Novel Coronavirus (COVID-19) Outbreak: A Review of the Current Literature , 2020 .
[233] The race to stop COVID-19 , 2020, The Pharmaceutical Journal.
[234] Jin-Lai Gao,et al. Injectable pegylated niclosamide (polyethylene glycol-modified niclosamide) for cancer therapy. , 2019, Journal of biomedical materials research. Part A.
[235] Shervanthi Homer-Vanniasinkam,et al. Latest developments in innovative manufacturing to combine nanotechnology with healthcare. , 2018, Nanomedicine.
[236] P. Stenvinkel,et al. Curcumin - A promising nutritional strategy for chronic kidney disease patients , 2018 .
[237] B. Schnierle,et al. Curcumin and Boswellia serrata gum resin extract inhibit chikungunya and vesicular stomatitis virus infections in vitro. , 2016, Antiviral research.
[238] A. Raza,et al. Turmeric : A Promising Spice for Phytochemical and Antimicrobial Activities , 2015 .
[239] M. Carafa,et al. Liposomal chemotherapeutics. , 2013, Future oncology.
[240] E. Patel. NANOSPONGE AND MICRO SPONGES: A NOVEL DRUG DELIVERY SYSTEM , 2012 .
[241] E. Riedmann. Chinese biotech partnership brings first hepatitis E vaccine to the market. , 2012, Human vaccines & immunotherapeutics.
[242] Murali M. Yallapu,et al. Curcumin nanoformulations: a future nanomedicine for cancer. , 2012, Drug discovery today.
[243] M. M. Rizvi,et al. Oral delivery of curcumin bound to chitosan nanoparticles cured Plasmodium yoelii infected mice. , 2012, Biotechnology advances.
[244] H. Hemilä,et al. Vitamin C for preventing and treating pneumonia. , 2007, The Cochrane database of systematic reviews.
[245] Jae-We Cho,et al. Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets. , 2007, International journal of molecular medicine.
[246] J. Atherton,et al. The effect of ascorbic acid on infection of chick-embryo ciliated tracheal organ cultures by coronavirus , 2005, Archives of Virology.
[247] Y. Guan,et al. Inhibition of SARS-associated coronavirus infection and replication by RNA interference. , 2003, JAMA.
[248] J. Siennicka,et al. [Importance of vitamin A deficiency in pathology and immunology of viral infections]. , 2002, Roczniki Panstwowego Zakladu Higieny.
[249] W. Fawzi,et al. Vitamin A supplements ameliorate the adverse effect of HIV-1, malaria, and diarrheal infections on child growth. , 2002, Pediatrics.
[250] N. Cox,et al. Global epidemiology of influenza: past and present. , 2000, Annual review of medicine.
[251] R. Sidwell,et al. Influenza virus resistance to neuraminidase inhibitors. , 1998, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[252] D. Faulds,et al. Nelfinavir. A review of its therapeutic efficacy in HIV infection. , 1998, Drugs.
[253] M. Neal Guentzel,et al. Escherichia, Klebsiella, Enterobacter, Serratia, Citrobacter, and Proteus , 1996 .
[254] J. Robotham,et al. The acute-phase response. , 1995, New horizons.
[255] W. Wooster,et al. Crystal structure of , 2005 .